Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UCHL1 | P09936 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 3/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.36 |
| ▸ | SPR | P35270 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL652482 | 0.87 | NR1H2 (0.42) | NR1H2NR1H3RETGPR119PIK3CA | |
| SCHEMBL653685 | 0.87 | RET (0.46) | NR1H2NR1H3RETGPR119 | |
| SCHEMBL3585756 | 0.86 | CHRNB2 (0.36) | — | |
| SCHEMBL652009 | 0.85 | GPR119 (0.45) | NR1H2NR1H3RETGPR119USP30 | |
| SCHEMBL650034 | 0.82 | GPR119 (0.43) | UCHL1NR1H2NR1H3RETGPR119 | |
| SCHEMBL650737 | 0.82 | GPR119 (0.43) | UCHL1NR1H2NR1H3RETGPR119 | |
| SCHEMBL654584 | 0.81 | CHRNB2 (0.47) | NR1H2NR1H3RETGPR119USP30 | |
| SCHEMBL650797 | 0.81 | CHRNB2 (0.47) | NR1H2NR1H3RETGPR119USP30 | |
| SCHEMBL649506 | 0.81 | RET (0.43) | NR1H2NR1H3RETGPR119PIK3CA | |
| SCHEMBL650661 | 0.81 | NR1H2 (0.42) | NR1H2NR1H3RETGPR119PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119635-B2 | Diazabicyclic central nervous system active agents | ABBOTT LABORATORIES (US) | 2012-02-21 | — | — | US | disclosed |
| EP-2298775-A1 | Diazabicyclic central nervous system active agents | Abbott Laboratories (US) | 2011-03-23 | — | — | EP | disclosed |